Atara Biotherapeutics: Q3 Earnings Snapshot

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $21.9 million in its third quarter.

On a per-share basis, the Thousand Oaks, California-based company said it had a loss of $2.93.

The drug developer posted revenue of $40.2 million in the period.

Atara Biotherapeutics shares have dropped 9% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $11.65, a climb of 81% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up